Publications by authors named "Oyungerel Dogsom"

Insulin promotes HepG2 cell proliferation by inducing phosphorylation of the pyruvate dehydrogenase E1α (PDHA1) subunit at Ser293, a mechanism distinct from normal liver tissue. This study investigates how phosphorylated PDHA1 drives hepatocellular carcinoma cell proliferation. We identified eukaryotic elongation factor-1γ (eEF-1γ) as a key binding protein interacting with p-PDHA1 in response to insulin, facilitating their nuclear translocation.

View Article and Find Full Text PDF

Epidermal growth factor (EGF) is known to be a critical stimulant for inducing the proliferation of glioma cancer cells. In our study, we observed that GST-RhoA binds to pyruvate kinase M2 (PKM2) in vitro. While EGF reduced the levels of RhoA protein, it significantly increased p-Y42 RhoA, as well as PKM1 and PKM2 in LN18 glioma cell line.

View Article and Find Full Text PDF

Cell migration is a crucial contributor to metastasis, a critical process associated with the mortality of cancer patients. The initiation of metastasis is triggered by epithelial-mesenchymal transition (EMT), along with the changes in the expression of EMT marker proteins. Inflammation plays a significant role in carcinogenesis and metastasis.

View Article and Find Full Text PDF

Inflammation plays a crucial role in tumorigenesis, primarily mediated by NF-κB. RhoA GTPases are instrumental in regulating the activation of NF-κB. Specifically, the phosphorylation of Tyrosine 42 on RhoA ensures the activation of NF-κB by directly activating the IKKβ associated with IKKγ (NEMO).

View Article and Find Full Text PDF
Article Synopsis
  • Insulin boosts cell growth and metabolism while lowering blood sugar levels, mainly by enhancing the activity of pyruvate dehydrogenase (PDH) in the liver.
  • In liver cancer cells (HepG2), insulin leads to an increase in phosphorylated PDH (p-PDHA1) levels and promotes cell proliferation.
  • The study found that p-PDHA1 forms a complex with pyruvate kinase M2 (PKM2) that moves to the nucleus, affecting gene expression related to cancer progression, specifically through increasing levels of the long intergenic non-protein coding gene LINC00273 and the EMT marker ZEB1.
View Article and Find Full Text PDF
Article Synopsis
  • * PKM2 is highly expressed in cancer cells and embryos, functioning both as a metabolic enzyme and a transcriptional regulator, while its counterpart PKM1 is dominant in differentiated cells.
  • * PKM2's posttranslational modifications allow it to relocate to the nucleus to regulate gene transcription and phosphorylate proteins, highlighting its importance in various cells like astrocytes and cancer cells for processes such as lactate production and energy supply.
View Article and Find Full Text PDF